NCT05134909

Brief Summary

The overall goal of this project is to improve the visual quality of individuals who have abnormal corneal conditions that alter the shape of their cornea (eg. keratoconus). Patients with an abnormal corneal shape have substantial lower and higher order aberrations (distortions in the eye). This results in reduced visual acuity which cannot be corrected by regular sphero-cylindrical correction. Compensating for these aberrations has been challenging due to difficulty measuring their wavefront aberrations accurately and, consequently, manufacturing the custom contact lenses with irregular optical profiles. This project is designed to systematically overcome these obstacles with a customized scleral and/or soft contact lens capable of compensating for the lower and higher order aberrations of the eye.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 26, 2021

Status Verified

November 1, 2021

Enrollment Period

2.3 years

First QC Date

November 11, 2021

Last Update Submit

November 23, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual acuity

    Snellen "Tumbling E" method will be used to determine the smallest visible letter that a subject can see.

    up to 2 months

  • Contrast sensitivity

    Light and dark sinusoidal stripes (Gabor gratings) will used to determine the smallest contrast that a subject can see.

    up to 2 months

Study Arms (1)

Study: Keratoconus

EXPERIMENTAL

Customized contact lenses will be fitted to each study subject based on their own optical defects.

Device: Customized contact lens

Interventions

The customized lenses are designed to correct the eye's optical aberrations.

Study: Keratoconus

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to read and understand the informed consent document in English
  • to 75 years of age
  • Received diagnosis of keratoconus by a clinician
  • Willing and able to follow instructions

You may not qualify if:

  • Has best corrected visual acuity of 20/20 or better in the keratoconic eye(s).
  • Normal/typical subjects
  • Is unable to handle, insert, remove or care for the study lenses.
  • Has any active anterior segment disease, pathology, or surgery affecting vision, refraction, or the ability to wear a contact lens
  • History of ocular pharmacological treatment
  • History of ocular trauma or surgery causing abnormal corneal curvature or distorted vision History of contact lens intolerance
  • Pregnant at the time of enrollment in the study (self-reported- It has been shown hormonal changes during pregnancy may affect corneal biomechanics negatively)
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers under the age of 18 because it has been shown the average age of the appearance of Keratoconus is the second decade of life ( 15-18 years of age)
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Geunyoung Yoon, PhD

    University of Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Geunyoung Yoon, PhD

CONTACT

Ayeswarya Ravikumar, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 11, 2021

First Posted

November 26, 2021

Study Start

November 1, 2021

Primary Completion

March 1, 2024

Study Completion

December 1, 2024

Last Updated

November 26, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share